Audience

Academic researchers, bioinformaticians, and pharmaceutical or biotech R&D teams seeking a no-code platform for multi-omics data analysis and visualization

About OmnibusX

In the world of biological data science, navigating vast and complex datasets can be a daunting task. Our software toolkit is designed to empower you by accelerating analysis, promoting accessibility, and providing comprehensive visualization tools to help you make sense of these intricate biological datasets.

Our platform is built with data accessibility at its core. With just a few clicks, you can gain seamless access to extensive, high-dimensional biological datasets, including bulk RNA-seq, single-cell RNA-seq, scATAC-seq, spatial RNA-seq, and metagenome-seq. This allows you to focus less on data wrangling and more on analysis and discovery.

Our integrated standard processing pipeline includes the latest tools for standard data processing. From normalization and batch correction to PCA, t-SNE, UMAP, clustering, cell type prediction, TCR/BCR, genome browser, and beyond, our pipeline is designed to streamline your workflow and provide you with reliable, reproducible results.

Pricing

Starting Price:
$45/month/user
Free Trial:
Free Trial available.

Integrations

API:
Yes, OmnibusX offers API access

Ratings/Reviews - 1 User Review

Overall 5.0 / 5
ease 4.0 / 5
features 5.0 / 5
design 4.0 / 5
support 5.0 / 5

Company Information

OmnibusX Company Limited
Founded: 2024
Vietnam
omnibusx.com

Videos and Screen Captures

Other Useful Business Software
Ship Agents Faster Icon
Ship Agents Faster

Transform your applications and workflows into powerful agentic systems at global scale.

Gemini Enterprise Agent Platform lets you rapidly build, scale, govern and optimize production-ready agents grounded in your organization's data. The platform enables developers to build custom or pre-built agents for virtually any use case. New customers get $300 in free credits.
Start Free

Product Details

Platforms Supported
Cloud
Windows
Mac
Linux
On-Premises
Training
Documentation
Live Online
In Person
Videos
Support
Online

OmnibusX Frequently Asked Questions

Q: What kinds of users and organization types does OmnibusX work with?
OmnibusX works with these users and organization types: Mid Size Business, Small Business, Enterprise, Freelance, Government, and Startup.
Q: What languages does OmnibusX support in their product?
OmnibusX supports these languages: English.
Q: What kind of support options does OmnibusX offer?
OmnibusX offers support via online.
Q: What other applications or services does OmnibusX integrate with?
OmnibusX integrates with: Amazon S3 and Python.
Q: Does OmnibusX have an API?
Yes, OmnibusX has an API.
Q: What type of training does OmnibusX provide?
OmnibusX provides training in the form of documentation, live online, in person, and videos.
Q: Does OmnibusX offer a free trial?
Yes, OmnibusX offers a free trial.
Q: How much does OmnibusX cost?
Pricing for OmnibusX starts at $45/month/user.

OmnibusX Product Features

OmnibusX Verified User Reviews

Write a Review
  • An OmnibusX User
    Principal Investigator
    Used the software for: 1-2 Years
    Frequency of Use: Monthly
    User Role: User
    Company Size: 26 - 99
    Design 4 out of 5 stars
    Ease 4 out of 5 stars
    Features 5 out of 5 stars
    Pricing 5 out of 5 stars
    Support 5 out of 5 stars
    Probability You Would Recommend? 10 out of 10

    "Pretty good"

    5 out of 5 stars Posted 2026-03-21

    Pros: - Custom plot editing: The latest release allows for editing of plots directly within OmnibusX, without the need to export and use external software.
    - The team showed a strong commitment to integrating new features.

    Cons: Initial use required a call to better understand certain advanced analysis features

    Overall: The application itself is very powerful. The new features are a massive improvement. I also appreciate how quickly the team was able to implement my suggestion, that kind of responsiveness and feature development is excellent.

    Read More...
  • Previous
  • You're on page 1
  • Next